By attending this conference you will:
- Assess the market growth available for CBA, what challenges face companies looking to expand their use of CBA technologies
- Investigate key techniques to solve toxicity problems earlier (“fail early” approach)
- Review advantages of CBA over Biochemical Assays
- Examine how to improve consistency and reproducibility of these tests
- Explore the advancements in 3D cell technology and why it’s preferential to 2D testing
- Discover the different types of cells available for use in CBA
- Acquiring new cells – availability of stem cells and diversity of uses
- Assays using stem cells – new developments and sites available for cell procurement and testing
- Review ethical and regulatory issues facing CBA
- Discover new technologies for labeled and non-labeled detection in CBA